Tuesday, July 19, 2016 9:18:57 AM
SpectraScience Appoints AMG as Exclusive Distributor in Middle East
Last update: 19/07/2016 9:15:00 am
SpectraScience Appoints AMG as Exclusive Distributor in Middle East
SAN DIEGO, CA--(Marketwired - Jul 19, 2016) - SpectraScience, Inc. (OTC PINK: SCIE), a medical device company utilizing light technologies to detect and diagnose cancers, announced today that they have signed a distribution agreement with Advanced Medical German Co. in Kuwait to be their exclusive distributor in the Middle East.
"We are pleased to be working with the premier distribution company for gastroenterology in the Middle East," said Michael Oliver, President and Chief Executive Officer of SpectraScience, Inc. "We believe that with our innovative products and the sales, marketing, and distribution acumen of AMG in the Middle East we are poised to bring a new level of diagnostic capability to clinicians in colorectal cancer screening."
"Introducing innovative medical devices to our customers that improve patient outcomes is a hallmark of AMG. We believe the WavSTAT Optical Biopsy System has the potential to make screening for colorectal cancer less invasive and safer for patients, faster and more efficient for clinicians and, overall, less expensive for the health care system," said Dr. EYAD, President of AMG. "That combination of factors is attractive in any medical device market."
About SpectraScience, Inc.:
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. Protected by more than 30 patents in 28 countries, covering fundamental elements of the technology, the WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative patent protected technology for clinical use.
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM